Zobrazeno 1 - 10
of 78
pro vyhledávání: '"I. I. Kalinina"'
Autor:
G. G. Solopova, D. D. Baidildina, L. I. Zharikova, I. I. Kalinina, U. N. Petrova, Ye. V. Suntsova, O. V. Goronkova, L. A. Hachatryan, V. V. Sinitsina, G. A. Novichkova, A. A. Maschan, M. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 8-15 (2022)
Standard therapy of high risk patients with Langerhans cell histiocytosis (LCH) is associated with essential risk of therapy failure. In the present study results of 2-clorodeoxyadenosine usage as alternative therapy in this group of patients are ana
Externí odkaz:
https://doaj.org/article/aff35ebb6ec14d3cbe54f0f6a680cf5f
Autor:
N. P. Kirsanova, O. V. Aleinikova, A. M. Kustanovich, T. V. Savitskay, R. I. Yutskevich, E. V. Volochnik, L. V. Baidun, Yu. E. Mareiko, Yu. S. Strongin, N. V. Minakovskay, N. V. Migal, I. V. Proleskovskay, I. V. Emelyanova, O. V. Karas, A. G. Drekov, M. M. Maschan, D. V. Litvinov, N. V. Myakova, E. V. Skorobogatova, D. D. Baidildina, I. I. Kalinina, G. G. Solopova, E. V. Suntsova, U. N. Petrova, L. A. Hachatryan, M. M. Scheider, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 1, Pp 5-13 (2022)
Protocol AML-MM-2000 treatment results of unfavorable prognostic group in children with primary acute myeloid leukemia (AML) in Russia and Belarus are presented. 105 children at the age from 2 weeks till 18 years (a median age — 10.8 years) are inc
Externí odkaz:
https://doaj.org/article/b5947a60a3844a338c3bdb12bb102b9d
Autor:
N. Yu. Shipovskaya, E. V. Samochatova, O. B. Polushkina, M. A. Maschan, I. I. Kalinina, A. N. Gracianskay, M. N. Kostileva, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 2, Pp 70-74 (2022)
Introduction of biosimilars in clinical practice results in substantial reduction of direct medical costs. However, limited data concerning safety and tolerance of biosimilars exist, especially in children. We conducted double blind randomized trial
Externí odkaz:
https://doaj.org/article/db4beeeafdcc46779093ed79607dbe40
Autor:
A. K. Ignatova, I. I. Kalinina, D. A. Venev, T. Yu. Salimova, D. A. Evseev, M. N. Sadovskaya, O. V. Goronkova, V. E. Matveev, U. N. Petrova, K. S. Antonova, D. D. Baydildina, M. E. Dubrovnaya, T. V. Konyukhova, Yu. V. Olshanskaya, D. S. Abramov, M. A. Maschan, G. A. Novichkova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 16, Iss 1, Pp 10-22 (2021)
Background. Extramedullary infiltration (EI) is relatively common in children with acute myeloid leukemia (AML) (up to 20-25 %). However, its clinical and prognostic significance remains poorly understood.Objective: to describe clinical features and
Externí odkaz:
https://doaj.org/article/14fb36d0acc24523992dfb11fa1cebf2
Autor:
I. I. Kalinina, M. M. Shneyder, N. P. Kirsanova, D. D. Baydildina, E. V. Suntsova, O. V. Goronkova, L. A. Khachatryan, G. A. Novichkova, M. A. Maschan, R. I. Yutskevich, E. V. Volochnik, T. V. Savitskaya, N. V. Minakovskaya, I. V. Proleskovskaya, I. V. Emelyanova, O. V. Karas, N. V. Migal, Yu. E. Mareyko, A. G. Drekov, J. V. Rumyantseva, E. V. Fleyshman, T. V. Nasedkina, O. V. Aleynikova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 6, Iss 1, Pp 11-19 (2014)
A t(8;21) is the most frequent abnormality in AML in children. Patients with this genetic abnormality are traditionally expected favorable prognosis with a probability of cure up to 80 %. Known additional cytogenetic abnormalities in AML with t(8;21)
Externí odkaz:
https://doaj.org/article/61550d5fd7a3461ea6fbd41aa62aeae6
Autor:
I. I. Kalinina, D. D. Baydildina, E. V. Suntsova, O. V. Goronkova, L. A. Khachatryan, U. N. Petrova, G. G. Solopova, V. V. Sinitsina, G. A. Novichkova, M. A. Maschan, D. V. Litvinov, N. V. Myakova, G. A. Klyasova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 6, Iss 3, Pp 24-34 (2014)
Candidemia is one of the most serious infectious complications in children with hematological malignancies and has a high morta lity rate.Seven-year experience of candidemia diagnosis and therapy in patients with various hematologic malignancies w as
Externí odkaz:
https://doaj.org/article/0b63a6c394fb460e8e396ab73b2366ad
Autor:
I. I. Kalinina, D. V. Litvinov, I. V. Veselova, N. I. Ponomareva, L. N. Shelikhova, V. V. Fominykh, G. A. Klyasova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 6, Iss 1, Pp 39-44 (2014)
Introduction: Invasive fungal infections (IFI) remain an unresolved issue of hematology/oncology despite the introduction of methods of early diagnostic and invent of new highly active antimycotics. In etiologic structure of IFI the leading role belo
Externí odkaz:
https://doaj.org/article/bd330a9adf8f4ccf83ffc01d9706fbee
Autor:
E. A. Matveeva, A. N. Kazakova, I. I. Kalinina, M. E. Dubrovina, L. V. Baydun, M. A. Maschan, Yu. V. Olshanskaya, A. A. Maschan
Publikováno v:
Онкогематология, Vol 7, Iss 2, Pp 51-56 (2014)
Acute megakaryocytic leukemia (AML M7) – a rare disease characterized by poor treatment response, except for t(1;22) variant in infants. Cytogenetic abnormalities in AML M7 are highly heterogeneous. We collected samples from children with AML M7 to
Externí odkaz:
https://doaj.org/article/3500caa759c74cc487b3235952011626
Autor:
I. I. Kalinina, U. N. Petrova, O. V. Goronkova, D. D. Baidildina, V. V. Sinitsyna, L. A. Khachatryan, M. A. Maschan, G. A. Klyasova, A. A. Maschan
Publikováno v:
Онкогематология, Vol 7, Iss 4, Pp 35-42 (2014)
Worldwide distribution of mold fungi and their extremely danger for immune compromise patients makes this issue one of the unsolved problems in modern oncology. Three cases of rare fungal infections in children with hematological malignancies are des
Externí odkaz:
https://doaj.org/article/5a921c6c078f49ea92b004e8e3471baa
Autor:
D. S. Osipova, E. V. Raykina, E. I. Lyudovskikh, D. A. Evseev, I. I. Kalinina, D. D. Baydildina, A. M. Popov, A. A. Semchenkova, E. A. Burtsev, G. O. Bronin, A. A. Maschan, M. A. Maschan
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:12-20
This article discusses the potential of droplet digital polymerase chain reaction (PCR) for the diagnostic detection and monitoring of the allelic load of the BRAF V600E mutation in circulating cell-free DNA and myeloid progenitor cell population in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4ddd9ce5ea4ca38ede49776d1c7366d
https://doi.org/10.24287/1726-1708-2023-22-1-12-20
https://doi.org/10.24287/1726-1708-2023-22-1-12-20